Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

Press releases published on June 22, 2026

28 minutes ago

Errante Reinforces Its Commitment to Client Experience with the Launch of Errante Pulse

Indeterminate GlobeNewswire

an hour ago

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

Indeterminate GlobeNewswire

an hour ago

Progress Toward Production at Globex’s Bell Mountain Nevada Royalty Property

Indeterminate GlobeNewswire

an hour ago

Parexel Launches Parexel Biotech Incubator to Connect Early-Stage Innovation with Clinical Development Expertise

Indeterminate GlobeNewswire

an hour ago

AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series

Indeterminate GlobeNewswire

an hour ago

Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion

Indeterminate GlobeNewswire

2 hours ago

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Indeterminate GlobeNewswire

2 hours ago

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

2 hours ago

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire

2 hours ago

Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Indeterminate GlobeNewswire

2 hours ago

Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum

Indeterminate GlobeNewswire

2 hours ago

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

Indeterminate GlobeNewswire

2 hours ago

Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis

Indeterminate GlobeNewswire

3 hours ago

BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026

Indeterminate GlobeNewswire

3 hours ago

DEEP SEA MINERALS CORP. WELCOMES G7 LEADERS’ DECLARATION ON SECURING CRITICAL MINERALS SUPPLY CHAINS

Indeterminate GlobeNewswire

3 hours ago

Lithium Argentina Reports 2026 Annual General Meeting Results

Indeterminate GlobeNewswire

3 hours ago

MapLight Announces Topline Results from Phase 2 IRIS Study for ML-004 in Autism Spectrum Disorder

Indeterminate GlobeNewswire

3 hours ago

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

Indeterminate GlobeNewswire

3 hours ago

Mirasol Provides Exploration Update on Sobek Copper-Gold Project in the Vicuña District, Chile

Indeterminate GlobeNewswire

4 hours ago

Zoomex X Space Recap With Djibril Cissé and the World Cup Trading Panel

Indeterminate GlobeNewswire